Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 669

Results For "MP"

10036 News Found

Lonza collaborates with AbTis to extend Bioconjugation capabilities
Biotech | November 30, 2022

Lonza collaborates with AbTis to extend Bioconjugation capabilities

Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox


Cipla launches Leuprolide Acetate Injection Depot ( (22.5 mg)
Drug Approval | November 30, 2022

Cipla launches Leuprolide Acetate Injection Depot ( (22.5 mg)

Leuprolide Acetate Injection Depot contains 22.5 mg of leuprolide acetate for 3- month administration given as a single dose injection.


Briefs: Lupin and GMM Pfaudler
News | November 30, 2022

Briefs: Lupin and GMM Pfaudler

The joint venture will help both the parties to further develop the high-margin service business


CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology
Drug Approval | November 30, 2022

CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology

South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe


Zydus enters into BTA for purchase from Watson Pharma
News | November 30, 2022

Zydus enters into BTA for purchase from Watson Pharma

The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.


AstraZeneca’s Dapagliflozin receives CDSCO approval
Drug Approval | November 30, 2022

AstraZeneca’s Dapagliflozin receives CDSCO approval

Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD


Granules India CFO Sandip Neogi resigns
People | November 29, 2022

Granules India CFO Sandip Neogi resigns

The company is in the process of appointing a new CFO.


Infosys Foundation opens second Diabetes Reversal Counselling Centre in Nagpur
Healthcare | November 29, 2022

Infosys Foundation opens second Diabetes Reversal Counselling Centre in Nagpur

Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others


Lupin's subsidiary MedQuimica acquires rights to nine brands from Bausch Health
News | November 29, 2022

Lupin's subsidiary MedQuimica acquires rights to nine brands from Bausch Health

The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness


Fredun Pharmaceuticals signs two large contracts
News | November 29, 2022

Fredun Pharmaceuticals signs two large contracts

Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports